![Keith Vendola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Vendola
Direttore Finanziario/CFO presso
NERVGEN PHARMA CORP.
Patrimonio netto: - $ in data 31/07/2026
Profilo
Keith A. Vendola is currently Chief Financial Officer at NervGen Pharma Corp.
Former positions include Senior Director-Business Development at Threshold Pharmaceuticals, Inc., Chief Financial Officer at Wugen, Inc., Head-Corporate Development at DiObex, Inc., Vice President-Finance & Corporate Development at Eiger BioPharmaceuticals, Inc., Chief of Staff & VP-Competitive Strategy at Coherus Oncology, Inc. from 2015 to 2017, Chief Strategy Officer at Rezolute, Inc. from 2020 to 2021, and Chief Financial Officer at IO Biotech, Inc. from 2021 to 2022.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts), a doctorate from Dartmouth Medical School, and an MBA from Kellogg School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NERVGEN PHARMA CORP. -.--% | 27/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Keith Vendola
| Società | Posizione | Inizio |
|---|---|---|
| NERVGEN PHARMA CORP. | Direttore Finanziario/CFO | 27/04/2026 |
Precedenti posizioni note di Keith Vendola
| Società | Posizione | Fine |
|---|---|---|
| IO BIOTECH, INC. | Direttore Finanziario/CFO | 09/05/2022 |
| REZOLUTE, INC. | Direttore Finanziario/CFO | 06/11/2020 |
| COHERUS ONCOLOGY, INC. | Ufficiale delle Risorse Umane | 01/06/2017 |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Direttore Finanziario/CFO | - |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Direttore Finanziario/CFO | - |
Formazione di Keith Vendola
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
38
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic disease treatment | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
 Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Technology Services |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
